CRT-13 Long-term Safety And Efficacy Of Drug-eluting Stents (DES) Versus Bare Metal Stents (BMS) in Public Health System Patients Stratified By Presentation Acuity At The Time Of Percutaneous Coronary Intervention (PCI)

The main benefit of DES vs. BMS in PCI is reduced revascularization. Recent data also suggest reduced major adverse cardiac events (MACE) with DES used in the context of MI yet many patients (pts), especially the uninsured do not receive DES. We evaluated BMS vs. DES in a public health system (PHS)